Cleared Traditional

CYSTICERCOSIS SEROLOGICAL REAGENTS (K900780) - FDA 510(k) Clearance

Class I Microbiology device.

K900780 · Lmd Laboratories · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1990
Decision
226d
Days
Class 1
Risk

K900780 is an FDA 510(k) clearance for the CYSTICERCOSIS SEROLOGICAL REAGENTS. Classified as Reagents, Cysticercosis (product code MDJ), Class I - General Controls.

Submitted by Lmd Laboratories (San Diego, US). The FDA issued a Cleared decision on October 4, 1990 after a review of 226 days - an extended review cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3200 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Lmd Laboratories devices

Submission Details

510(k) Number K900780 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 20, 1990
Decision Date October 04, 1990
Days to Decision 226 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
124d slower than avg
Panel avg: 102d · This submission: 226d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code MDJ Reagents, Cysticercosis
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3200
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.